The Great Healthcare Debate 7 DAYS · Free panel + drinks · 12 May · London RSVP free →

Transgenic tobacco plants product active IL-10

23 March 2009

A team of European scientists led by Mario Pezzoti of the University of Verona, Italy, have developed transgenic tobacco plants that can  produce biologically-active interleukin-10, an important cytokine.  The research, which was part of the Pharma-Planta Project, found that  the plants were able to process both viral and mouse forms of IL-10  correctly, producing the active cytokine at high enough levels that it  might be possible to use tobacco leaves without lengthy extraction and  purification processes. The next step will be to test the plants by  feeding them to mice with autoimmune diseases, the authors noted.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight